Butler Stephen F, Faraone Stephen V, Rostain Anthony L, Newcorn Jeffrey H, Antshel Kevin M, Robbins Rebekkah S, Green Jody L
Inflexxion, an IBH Company, Irvine, CA, United States.
Departments of Psychiatry and of Neuroscience and Physiology, The State University of New York (SUNY) Upstate Medical University, Syracuse, NY, United States.
Front Psychiatry. 2021 Aug 16;12:667118. doi: 10.3389/fpsyt.2021.667118. eCollection 2021.
Non-medical use (NMU) of prescription stimulant medications is a continuing public health concern. Stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) are widely available on college campuses, and, as a consequence, college students may have multiple opportunities to engage in prescription stimulant NMU. This online self-report survey examined prescription stimulant NMU among college students, including: (1) patterns of non-oral route of administration (ROA); (2) motivations for non-oral ROAs; and (3) retrospectively recalled pathways of initiation. The survey sample was created from a pool of 3,379 respondents, who were matched to a sampling frame constructed from the 18-26-year-old, college student sample of the 2016 American Community Survey (ACS). About 14% ( = 486) from the overall pool were identified as college students with self-reported prescription stimulant NMU, all of whom completed the survey. The survey covered user characteristics, prescription and illicit substance use, age of first NMU, motivations for NMU, sources of procurement, and ROAs used. Among 486 students reporting prescription stimulant NMU, 43% had a lifetime diagnosis of ADHD. More than 90% reported polysubstance use, with 55% using illicit substances other than marijuana. Slightly more than 2 in 5 (43.3%) reported using illicit substances prior to prescription stimulant NMU, 24.6% used both at the same age, and 32.0% engaged in NMU of prescription stimulants prior to using illicit substances. Prescription stimulant NMU preceded prescription opioid NMU 45% of the time. More than a quarter of those engaged in prescription stimulant NMU (27.9%) initiated prescription stimulants alone or at the same age as other drugs. Most prescription stimulant NMU was oral, however 23.0% reported any non-oral use: snorting (20.4%), smoking (6.0%)and/or injection (3.5%). Non-oral use was associated with being male, obtaining medication from a dealer, use to get high, and/or a substance use disorder diagnosis. Prescription stimulant NMU often occurs in the larger context of other substance use among college students. Injection, an under-researched route for prescription stimulants, was associated with male gender, history of substance use and higher likelihood of illicit substance use. Nearly a quarter of college student survey respondents reported use with non-oral routes, which is associated with other high-risk behaviors. Efforts to reduce non-oral prescription stimulant NMU in college students are warranted.
处方兴奋剂药物的非医疗使用(NMU)一直是公共卫生关注的问题。用于治疗注意力缺陷多动障碍(ADHD)的兴奋剂药物在大学校园广泛可得,因此,大学生可能有多次机会参与处方兴奋剂的非医疗使用。这项在线自我报告调查研究了大学生中的处方兴奋剂非医疗使用情况,包括:(1)非口服给药途径(ROA)模式;(2)非口服给药途径的动机;(3)回顾性回忆的开始使用途径。调查样本来自3379名受访者,这些受访者与根据2016年美国社区调查(ACS)中18 - 26岁大学生样本构建的抽样框架相匹配。总体样本中约14%(=486人)被确定为有自我报告的处方兴奋剂非医疗使用的大学生,他们都完成了调查。该调查涵盖了使用者特征、处方和非法药物使用、首次非医疗使用的年龄、非医疗使用的动机、采购来源以及使用的给药途径。在486名报告有处方兴奋剂非医疗使用的学生中,43%曾被诊断患有ADHD。超过90%的人报告使用多种物质,其中55%使用除大麻以外的非法药物。略多于五分之二(43.3%)的人报告在开始非医疗使用处方兴奋剂之前使用过非法药物,24.6%的人在同一年龄段同时使用两者,32.0%的人在使用非法药物之前就开始非医疗使用处方兴奋剂。45%的情况下,处方兴奋剂的非医疗使用先于处方阿片类药物的非医疗使用。超过四分之一参与处方兴奋剂非医疗使用的人(27.9%)单独开始使用处方兴奋剂或与其他药物在同一年龄段开始使用。大多数处方兴奋剂的非医疗使用是口服,但23.0%的人报告有任何非口服使用:吸食(20.4%)、吸烟(6.0%)和/或注射(3.5%)。非口服使用与男性、从经销商处获取药物、为了兴奋而使用以及/或者物质使用障碍诊断有关。处方兴奋剂的非医疗使用通常发生在大学生其他物质使用的更大背景下。注射是处方兴奋剂研究较少的给药途径,与男性性别、物质使用史以及更高的非法药物使用可能性有关。近四分之一的大学生调查受访者报告有非口服使用情况,这与其他高风险行为有关。有必要努力减少大学生中非口服处方兴奋剂的非医疗使用。